This paper lays down the system under which a pharmaceutical company wishing to supply medicinal products to the NHS hospital service is assessed if a visit is considered necessary prior to addition to lists of suppliers.

Quality audit protocols and a suitable report format are included.

Assessment of commercial aspects of companies is not covered in this document.